GlassScriptPhysician profile
Elizabeth Ann Doerr
NPI 1992453013
$1,212.15
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $376 · 2023: $491 · 2024: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $296.58 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $237.35 | 2022-2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $135.18 | 2022-2023 | Lokelma |
| Ascensia Diabetes Care US INC. | $119.04 | 2022-2024 | |
| Lilly USA, LLC | $75.84 | 2022-2024 | Mounjaro, Zepbound |
| Insulet Corporation | $65.72 | 2023-2024 | Omnipod |
| Abbvie INC. | $63.92 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $47.44 | 2022-2023 | |
| Ibsa Pharma INC. | $41.29 | 2022-2024 | Tirosint, Licart, Licart |
| Corcept Therapeutics | $27.15 | 2022-2023 | Korlym |
| Ipsen Biopharmaceuticals, INC | $21.16 | 2022 | |
| Beta Bionics, INC. | $21.12 | 2023 | Ilet Bionic Pancreas |
| Amneal Pharmaceuticals LLC | $16.22 | 2024 | Unithroid |
| Medtronic, INC. | $15.88 | 2024 | Abre |
| Xeris Pharmaceuticals, INC. | $14.44 | 2024 | Gvoke Hypopen |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $13.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Doerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.